Metavasi Capital’s Oracle ORCL Stock Holding History

Metavasi Capital’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-70,000	Closed	-$6.5M	–	34
2023 Q1	$6.5M	Buy	+70,000	New	+$6.14M	4.85%	5

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Metavasi Capital's ORCL Position: Q2 2023 in Review

Metavasi Capital sold out of Oracle (ORCL) in Q2 2023, closing a stake of 70,000 shares — an estimated $6.5M sold.

Metavasi Capital first reported a position in ORCL in Q1 2023 and held it in 1 quarter. The position peaked at $6.5M in Q1 2023. 2,564 funds tracked by Wall St. Rank hold ORCL as of Q2 2023.

Metavasi Capital reported no remaining Oracle position as of Q2 2023 after selling out during the quarter.
Metavasi Capital sold 70,000 Oracle shares in Q2 2023, an estimated $6.5M.
Metavasi Capital first reported a position in Oracle in Q1 2023 and held it in 1 quarter.
Metavasi Capital's Oracle position peaked at $6.5M in Q1 2023.
2,564 funds tracked by Wall St. Rank held Oracle as of Q2 2023.

Based on Metavasi Capital's 13F filing for Q2 2023, filed 14 Aug 2023.